ImmunoPrecise Antibodies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IPA and buy or sell other stocks, ETFs, and their options commission-free!About IPA
MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. It operates through the following geographical segments: United States of America, Europe, Canada, Australia, and Other.
CEOJennifer L. Bath, PhD
CEOJennifer L. Bath, PhD
Employees102
Employees102
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1983
Founded1983
Employees102
Employees102
IPA Key Statistics
Market cap86.77M
Market cap86.77M
Price-Earnings ratio-3.19
Price-Earnings ratio-3.19
Dividend yield—
Dividend yield—
Average volume383.88K
Average volume383.88K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.25
52 Week high$3.25
52 Week low$0.27
52 Week low$0.27
Stock Snapshot
ImmunoPrecise Antibodies(IPA) stock is priced at $1.88, giving the company a market capitalization of 86.77M. It carries a P/E multiple of -3.19.
On 2025-12-10, ImmunoPrecise Antibodies(IPA) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for ImmunoPrecise Antibodies(IPA) stock has reached 0, versus its average volume of 383.88K.
The stock's 52-week range extends from a low of $0.27 to a high of $3.25.
The stock's 52-week range extends from a low of $0.27 to a high of $3.25.
People also own
Based on the portfolios of people who own IPA. This list is generated using Robinhood data, and it’s not a recommendation.